Chaaru Deb focuses on patent and trade secret litigation in federal and state courts. With a background in Biological Engineering, Chaaru is able to bring an understanding of a wide range of technologies to her legal practice.
During law school, Chaaru advised early-stage biotech start-ups on various topics, including intellectual property strategy. She also has prior experience working with the USPTO’s Biotechnology and Organic fields technology center and the Office of Policy and International Affairs. Prior to law school, Chaaru’s biological engineering research focused on stem cell therapeutics, single-cell RNA sequencing, and computational biology. Chaaru maintains an active pro bono practice.
Qualifications
Bar Qualification
California
US Patent and Trademark Office
Education
JD, Yale Law School, 2021
BS in Biological Engineering, Massachusetts Institute of Technology, 2018
Two Latham litigation teams recognized for securing a rare preliminary injunction in biosimilar patent litigation for J&J’s Jassen and a first-round dismissal with prejudice of a securities class action on behalf of VinFast.
A Latham litigation team secured dismissal with prejudice of an antitrust class action challenging Novartis’ listing of Entresto-related patents in the FDA’s Orange Book.
Notice: We appreciate your interest in Latham & Watkins. If your inquiry relates to a legal matter and you are not already a current client of the firm, please do not transmit any confidential information to us. Before taking on a representation, we must determine whether we are in a position to assist you and agree on the terms and conditions of engagement with you. Until we have completed such steps, we will not be deemed to have a lawyer-client relationship with you, and will have no duty to keep confidential the information we receive from you. Thank you for your understanding.